• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

导管原位癌——当前的治疗方法

Ductal carcinoma in situ--current management.

作者信息

O'Sullivan Martin J, Morrow Monica

机构信息

Department of Surgical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111-2497, USA.

出版信息

Surg Clin North Am. 2007 Apr;87(2):333-51, viii. doi: 10.1016/j.suc.2007.01.006.

DOI:10.1016/j.suc.2007.01.006
PMID:17498530
Abstract

This article summarizes the modern evidence-based management of ductal carcinoma in situ. The data addressing the surgical issues, including indications for mastectomy and the use of sentinel node biopsy, are presented. The randomized trials examining the role of radiation therapy after breast-conserving surgery and the use of tamoxifen in ductal carcinoma in situ are discussed. Factors to consider in developing a management strategy for the individual patient are elucidated in the final section.

摘要

本文总结了导管原位癌的现代循证管理。文中呈现了涉及手术问题的数据,包括乳房切除术的适应证以及前哨淋巴结活检的应用。讨论了关于保乳手术后放疗作用以及他莫昔芬在导管原位癌中应用的随机试验。最后一部分阐明了为个体患者制定管理策略时需考虑的因素。

相似文献

1
Ductal carcinoma in situ--current management.导管原位癌——当前的治疗方法
Surg Clin North Am. 2007 Apr;87(2):333-51, viii. doi: 10.1016/j.suc.2007.01.006.
2
The role of radiation therapy after local excision of invasive and noninvasive breast cancer.浸润性和非浸润性乳腺癌局部切除术后放射治疗的作用。
Surg Oncol Clin N Am. 1997 Apr;6(2):359-79.
3
Review of breast cancer clinical trials conducted by the National Surgical Adjuvant Breast Project.由国家外科辅助乳腺项目开展的乳腺癌临床试验综述。
Surg Clin North Am. 2007 Apr;87(2):279-305, vii. doi: 10.1016/j.suc.2007.02.005.
4
Impact of randomized clinical trial results in the national comprehensive cancer network on the use of tamoxifen after breast surgery for ductal carcinoma in situ.国家综合癌症网络中随机临床试验结果对原位导管癌乳房手术后他莫昔芬使用情况的影响。
J Clin Oncol. 2007 Aug 1;25(22):3251-8. doi: 10.1200/JCO.2006.10.2699. Epub 2007 Jun 18.
5
[Breast-conserving surgery for ductal carcinoma in situ of the breast].[乳腺癌导管原位癌的保乳手术]
Nihon Rinsho. 2012 Sep;70 Suppl 7:528-32.
6
Sentinel lymph node biopsy for breast cancer.乳腺癌前哨淋巴结活检
J Insur Med. 2001;33(2):195-7.
7
The surgical management of ductal carcinoma in situ.导管原位癌的外科治疗。
Breast J. 2010 Sep-Oct;16 Suppl 1:S49-52. doi: 10.1111/j.1524-4741.2010.01005.x.
8
Ductal carcinoma-in-situ.导管原位癌
J Clin Oncol. 2001 Sep 15;19(18 Suppl):98S-100S.
9
Contemporary treatment of ductal carcinoma in situ of the breast.当代乳腺导管原位癌的治疗
Med Sci Monit. 2005 Mar;11(3):RA86-93.
10
Tamoxifen in ductal carcinoma in situ.他莫昔芬用于导管原位癌
Semin Oncol. 2006 Dec;33(6):647-9. doi: 10.1053/j.seminoncol.2006.08.019.

引用本文的文献

1
Development and Validation of the BREAST-Q Breast-Conserving Therapy Module.BREAST-Q 保乳治疗模块的制定与验证。
Ann Surg Oncol. 2020 Jul;27(7):2238-2247. doi: 10.1245/s10434-019-08195-w. Epub 2020 Jan 21.
2
Treatment results in patients with ductal carcinoma in situ treated with adjuvant radiotherapy.辅助放疗治疗导管原位癌患者的治疗结果。
Turk J Med Sci. 2019 Aug 8;49(4):1151-1156. doi: 10.3906/sag-1810-53.
3
Co-Expression of p16, Ki67 and COX-2 Is Associated with Basal Phenotype in High-Grade Ductal Carcinoma In Situ of the Breast.
p16、Ki67和COX-2的共表达与乳腺高级别导管原位癌的基底样表型相关。
J Histochem Cytochem. 2015 Jun;63(6):408-16. doi: 10.1369/0022155415576540. Epub 2015 Feb 23.
4
Immunohistochemical profile of high-grade ductal carcinoma in situ of the breast.乳腺高级别导管原位癌的免疫组织化学特征。
Clinics (Sao Paulo). 2013 May;68(5):674-8. doi: 10.6061/clinics/2013(05)15.
5
Ductal carcinoma in situ: terminology, classification, and natural history.导管原位癌:术语、分类及自然史
J Natl Cancer Inst Monogr. 2010;2010(41):134-8. doi: 10.1093/jncimonographs/lgq035.